Loading...
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic protein are elevated in diabetes and insulin resista...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003717/ https://ncbi.nlm.nih.gov/pubmed/33804680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22063170 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|